{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0010133785",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# AlzeCure Pharma AB (First North Sweden: SE0010133785) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is AlzeCure Pharma AB, listed on First North Sweden under ticker SE0010133785, with ISIN SE0010133785 and LEI 5493001EJLEBXFY6I446. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 38 filings on 36 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-10-27, 10 days before the record date of 2026-11-06, and its type is Changes in board/management/certified adviser/auditor/liquidity provider. The exchange median is 21 filings, 11.0 days median cadence gap and 7 days median latency across 325 issuers on First North Sweden; the issuer's 38 filings are above that median. The sector median state is not on the record.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither is its location. Auditor changes are not on the record, because the register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1 as of 2026-11-04, because the chapter's orderability section carries no client categories.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page as read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market earliest sealed date is not on the record, and the live record began is not on the record.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0010133785 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0010133785 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0010133785",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Changes in board/management/certified adviser/auditor/liquidity provider": 1,
    "Company description / prospectus": 1,
    "Corporate Action": 5,
    "Decisions of general meeting": 1,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Inside information": 2,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 22,
    "Notice to general meeting": 1
   },
   "cadence_median_gap_days": 7,
   "filing_days": 36,
   "filings": 38,
   "latency_days": 10,
   "latest": [
    {
     "category": "Changes in board/management/certified adviser/auditor/liquidity provider",
     "date": "2026-10-27",
     "source": "https://view.news.eu.nasdaq.com/view?id=b558e0b8837cd85f607b1f7ef8b6ac258&lang=en&src=listed",
     "title": "AlzeCure Pharma announces change of CEO ahead of next phase of development",
     "type": "Changes in board/management/certified adviser/auditor/liquidity provider"
    },
    {
     "category": "Investor News",
     "date": "2026-10-08",
     "source": "https://view.news.eu.nasdaq.com/view?id=b0768cd02d3352eb251ee905224e8120d&lang=en&src=listed",
     "title": "AlzeCure Pharma to present at Aktiespararna in Stockholm on 14 October",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-07",
     "source": "https://view.news.eu.nasdaq.com/view?id=b6c292910063d7a5b78c02f722132c33f&lang=en&src=listed",
     "title": "AlzeCure Pharma to present at Redeye Neurology Day on October 15",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-09-22",
     "source": "https://view.news.eu.nasdaq.com/view?id=bb0ca93b002621d0366c8aa20cb943d63&lang=en&src=listed",
     "title": "AlzeCure Pharma to present at Swiss Nordic Bio 2026 in Zurich",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-09-18",
     "source": "https://view.news.eu.nasdaq.com/view?id=b8f91aea806bd4a666a39546541b30dbc&lang=en&src=listed",
     "title": "AlzeCure Pharma publishes updated company presentation following the Eli Lilly and QuantumCell agreements",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0010133785",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0010133785"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0010133785)",
    "state": "sourced",
    "value": "5493001EJLEBXFY6I446"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "AlzeCure Pharma AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0010133785"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:9d550bf89debb9a6ee99da807a5d09f462bedd34dd8de4ea92367b7a54e94251",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0010133785",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9d550bf89debb9a6ee99da807a5d09f462bedd34dd8de4ea92367b7a54e94251",
 "path": "/se/SSME/SE0010133785",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is AlzeCure Pharma AB, listed on First North Sweden under ticker SE0010133785, with ISIN SE0010133785 and LEI 5493001EJLEBXFY6I446. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 38 filings on 36 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-10-27, 10 days before the record date of 2026-11-06, and its type is Changes in board/management/certified adviser/auditor/liquidity provider. The exchange median is 21 filings, 11.0 days median cadence gap and 7 days median latency across 325 issuers on First North Sweden; the issuer's 38 filings are above that median. The sector median state is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and neither is its location. Auditor changes are not on the record, because the register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1 as of 2026-11-04, because the chapter's orderability section carries no client categories.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page as read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market earliest sealed date is not on the record, and the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0010133785"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0010133785"
  }
 ],
 "title": "AlzeCure Pharma AB (SE0010133785) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}